The value of distinguishing patients with isolated subsegmental pulmonary embolism presenting to two tertiary hospitals in Australia: an observational study Yogesh SharmaSubodha SumanadasaCampbell Thompson OriginalPaper 19 June 2023 Pages: 215 - 225
On-treatment platelet reactivity through the thromboxane A2 or P2Y12 platelet receptor pathways is not affected by pelacarsen Ewa Karwatowska-ProkopczukLu LiSotirios Tsimikas OriginalPaper 20 June 2023 Pages: 226 - 232
Bleeding related hospitalizations and mortality in England 2014–2019 Katherine J. CreeperAndrew C. StaffordAlexander T. Cohen OriginalPaper 20 June 2023 Pages: 233 - 240
Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis Mehrdad RostamiHassan Mansouritorghabeh ReviewPaper 23 May 2023 Pages: 241 - 252
Neutrophil extracellular traps (NETs), transfusion requirements and clinical outcomes in orthotopic liver transplantation Ana Paula Hitomi YokoyamaJose Mauro KutnerFernanda Loureiro de Andrade Orsi OriginalPaper 25 May 2023 Pages: 253 - 263
Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention Hang ChiYibing ShaoJihe Li OriginalPaper 07 June 2023 Pages: 264 - 274
The potential role of micro-RNA 125b-5p level in predicting outcome from thrombolytic therapy in patients with acute ischemic stroke Sara MostafaHatem Al MasryMohammed M. Masoud OriginalPaper Open access 08 June 2023 Pages: 275 - 282
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme Justin J. W. GarabonMichael B. Boffa OriginalPaper 13 June 2023 Pages: 283 - 290
Machine learning analyses constructed a novel model to predict recurrent thrombosis in adults with essential thrombocythemia Jia ChenHuan DongLei Zhang OriginalPaper 30 May 2023 Pages: 291 - 300
Positive antiphospholipid antibodies: observation or treatment? Bogna Grygiel-GórniakŁukasz Mazurkiewicz ReviewPaper Open access 01 June 2023 Pages: 301 - 314
Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds Jason J. KeinathJona LekuraMathew C. Jones OriginalPaper 08 June 2023 Pages: 315 - 322
Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis S. LigiaP. MusiuAntonio Chistolini BriefCommunication 21 June 2023 Pages: 323 - 326
Prediction of in-hospital deterioration in normotensive pulmonary embolism remains elusive: external validation of the calgary acute pulmonary embolism score S. Nabeel HyderSayhaan R GorayaGeoffrey D Barnes OriginalPaper 23 June 2023 Pages: 327 - 332
The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis Huasong HuoShurui ShenYunqian Li ReviewPaper 21 June 2023 Pages: 333 - 341
Cerebral infarction and in-hospital mortality for patients admitted to hospital with intracardiac thrombus: insights from the National Inpatient Sample Chun Shing KwokKirellos Said AbbasGregory Y. H. Lip OriginalPaper 05 June 2023 Pages: 342 - 350
Clonal haematopoiesis of indeterminate potential in patients with venous thromboembolism Florence GuillotinÉric MercierJean-Christophe Gris BriefCommunication 10 June 2023 Pages: 351 - 354
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia Zain M. VirkT. Lee RichardsonHanny Al-Samkari BriefCommunication 20 June 2023 Pages: 355 - 359
Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate S. Scott SuttonJoseph MagagnoliJames W. Hardin Publisher Correction Open access 12 June 2023 Pages: 360 - 360
